-

ZOLL Reports Email Phishing Attack

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (“ZOLL”) is notifying individuals who were in contact with ZOLL Respicardia either directly or indirectly through a provider, or whose provider contacted ZOLL Respicardia on their behalf, that their health information may have been accessed by an unauthorized party after a ZOLL employee was the victim of a sophisticated email phishing attack. This incident was limited to emails and had no impact on ZOLL’s medical devices, software, or services. The information affected by the incident may have included some individuals’ names and health information. ZOLL has no indication that the information has been misused. ZOLL is evaluating its cybersecurity education and training measures for employees. Individuals with questions can contact a dedicated call center at 800-459-4255 Monday through Friday from 8 a.m. to 8 p.m. CST, closed Saturday and Sunday (and excluding major U.S. holidays).

Contacts

Matt Hogan
ZOLL
+1 (978) 805-6561
media@zoll.com

ZOLL Medical Corporation


Release Versions

Contacts

Matt Hogan
ZOLL
+1 (978) 805-6561
media@zoll.com

More News From ZOLL Medical Corporation

PulsePoint and ZOLL Accelerate Growth of National Emergency AED Registry, Helping More Communities Locate and Use Devices When Seconds Count

PLEASANTON, Calif. & CHELMSFORD, Mass.--(BUSINESS WIRE)--The PulsePoint Foundation, a public non-profit 501(c)(3) that builds public safety applications and maintains the National Emergency AED Registry (NEAR), and ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, including automated external defibrillators (AEDs), announces a new initiative, Anyone Can Register. The program will rally volunteers, AED owners, and AED manufacturers to expand NEAR so...

The Most Comfortable LifeVest® WCD Ever: ZOLL Completes Full U.S. Launch of Next Generation Garment

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the complete U.S. rollout of its next generation garment for the LifeVest® wearable cardioverter defibrillator (WCD). With continuous innovation and enhancements for patient comfort, this marks the third advancement of the LifeVest garment over the last five years. "The next generation LifeVest garment is a significant step forward in patient comfort and...

New ZOLL Zenix Monitor/Defibrillator Receives FDA Approval

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from y...
Back to Newsroom